Labetalol steady‐state pharmacokinetics in hypertensive patients.

JJ McNeil; AE Anderson; WJ Louis; K. Raymond

doi:10.1111/j.1365-2125.1982.tb01892.x

Labetalol steady‐state pharmacokinetics in hypertensive patients.

JJ McNeil, AE Anderson, WJ Louis, K. Raymond

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

13 Citations (Scopus)

Abstract

1 During chronic treatment of hypertensive patients observed mean steady‐state plasma labetalol levels in ten patients were consistently and significantly higher than predicted from initial acute pharmacokinetic analysis. 2 Mean steady‐state levels varied from 36 to 183 ng/ml on a chronic dose of 200 mg twice daily. 3 Patients with lower steady‐state levels on a fixed dose of labetalol usually required higher maintenance doses to control blood pressure. 1982 The British Pharmacological Society

Original language	English
Pages (from-to)	75S-80S
Journal	British Journal of Clinical Pharmacology
Volume	13
Issue number	1 S
DOIs	https://doi.org/10.1111/j.1365-2125.1982.tb01892.x
Publication status	Published - 1 Jan 1982

Access to Document

10.1111/j.1365-2125.1982.tb01892.x

Cite this

@article{9a1ec8064e5a4f28808d1c3c2755e127,

title = "Labetalol steady‐state pharmacokinetics in hypertensive patients.",

abstract = "1 During chronic treatment of hypertensive patients observed mean steady‐state plasma labetalol levels in ten patients were consistently and significantly higher than predicted from initial acute pharmacokinetic analysis. 2 Mean steady‐state levels varied from 36 to 183 ng/ml on a chronic dose of 200 mg twice daily. 3 Patients with lower steady‐state levels on a fixed dose of labetalol usually required higher maintenance doses to control blood pressure. 1982 The British Pharmacological Society",

author = "JJ McNeil and AE Anderson and WJ Louis and K. Raymond",

year = "1982",

month = jan,

day = "1",

doi = "10.1111/j.1365-2125.1982.tb01892.x",

language = "English",

volume = "13",

pages = "75S--80S",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell",

number = "1 S",

}

TY - JOUR

T1 - Labetalol steady‐state pharmacokinetics in hypertensive patients.

AU - McNeil, JJ

AU - Anderson, AE

AU - Louis, WJ

AU - Raymond, K.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - 1 During chronic treatment of hypertensive patients observed mean steady‐state plasma labetalol levels in ten patients were consistently and significantly higher than predicted from initial acute pharmacokinetic analysis. 2 Mean steady‐state levels varied from 36 to 183 ng/ml on a chronic dose of 200 mg twice daily. 3 Patients with lower steady‐state levels on a fixed dose of labetalol usually required higher maintenance doses to control blood pressure. 1982 The British Pharmacological Society

AB - 1 During chronic treatment of hypertensive patients observed mean steady‐state plasma labetalol levels in ten patients were consistently and significantly higher than predicted from initial acute pharmacokinetic analysis. 2 Mean steady‐state levels varied from 36 to 183 ng/ml on a chronic dose of 200 mg twice daily. 3 Patients with lower steady‐state levels on a fixed dose of labetalol usually required higher maintenance doses to control blood pressure. 1982 The British Pharmacological Society

UR - http://www.scopus.com/inward/record.url?scp=0020148625&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.1982.tb01892.x

DO - 10.1111/j.1365-2125.1982.tb01892.x

M3 - Article

C2 - 7093102

AN - SCOPUS:0020148625

VL - 13

SP - 75S-80S

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 1 S

ER -

Labetalol steady‐state pharmacokinetics in hypertensive patients.

Abstract

Access to Document

Other files and links

Cite this